PROSTATE CANCER TREATMENT NIGERIA OPTIONS

Smaller medical trials comparing them head-to-head at the different stages of prostate cancer could be needed. This might be carried out with asymptomatic Males who may have early Innovative-stage prostate cancer (e.g. PSA > 60 ng/ml); a downward adjust of PSA could be quickly utilised as being a appropriate biomarker endpoint in comparatively smal